Prevalence of Endometriosis in 9 Major Markets 2015-2025

36 pages


This report provides the current prevalence of Endometriosis in 9 major markets.


Endometriosis is a gynaecological condition where tissue that normally behaves like the lining of the womb (endometrium) is found outside the womb. These pieces of tissue are commonly found on the ovaries and the lining of the pelvis behind the uterus. This is a chronic condition that causes heavy periods, lower abdominal pain and can cause fertility issues. This report provides the current prevalence for Endometriosis across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of Endometriosis. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of the disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for the disease include:

  • Infertility
  • Pelvic Pain
  • Fibroids
  • Ovarian cysts

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Endometriosis’s market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Endometriosis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Endometriosis’s prevalence.
  • Examination of the prevalence of the different causative gene mutations for Endometriosis.
  • Identify sub-populations within Endometriosis which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Endometriosis patients.

You may also like…

    Epiomic Database


    A robust source of evidence-based patients for diseases, hospital admissions and procedures across healthcare markets.

Download your FREE table of contents!

Buy Report

This report provides the current prevalence of Endometriosis in 9 major markets.